Evidence map›Paper›PMID 31552675›Full record

ArticleFEBS letters2020

Enterococcus faecalis α1-2-mannosidase (EfMan-I): an efficient catalyst for glycoprotein N-glycan modification.

Yanhong Li, Riyao Li, Hai Yu, Xue Sheng, Jing Wang, Andrew J Fisher, Xi Chen

Open access · bronzeAbstract read
In one paragraph

Article in FEBS letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Gut · 2024
    Article
  4. Complete Genome Analysis ofMicroorganisms · 2023
    Article
  5. Article
  6. Article
  7. PlantProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yanhong LiDepartment of Chemistry, University of California, Davis, CA, USA.
Riyao LiDepartment of Chemistry, University of California, Davis, CA, USA.
Hai YuDepartment of Chemistry, University of California, Davis, CA, USA.
Xue ShengDepartment of Chemistry, University of California, Davis, CA, USA.
Jing WangDepartment of Chemistry, University of California, Davis, CA, USA.
Andrew J FisherDepartment of Chemistry, University of California, Davis, CA, USA.
Xi ChenDepartment of Chemistry, University of California, Davis, CA, USA.ORCID 0000-0002-3160-614X
University of California, Davis · USChinese Academy of Sciences · CN

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
NIGMS NIH HHS P41 GM103393
6 · The paper itself

Abstract

While multiple α 1-2-mannosidases are necessary for glycoprotein N-glycan maturation in vertebrates, a single bacterial α1-2-mannosidase can be sufficient to cleave all α1-2-linked mannose residues in host glycoprotein N-glycans. We report here the characterization and crystal structure of a new α1-2-mannosidase (EfMan-I) from Enterococcus faecalis, a Gram-positive opportunistic human pathogen. EfMan-I catalyzes the cleavage of α1-2-mannose from not only oligomannoses but also high-mannose-type N-glycans on glycoproteins. Its 2.15 Å resolution crystal structure reveals a two-domain enzyme fold similar to other CAZy GH92 mannosidases. An unexpected potassium ion was observed bridging two domains near the active site. These findings support EfMan-I as an effective catalyst for in vitro N-glycan modification of glycoproteins with high-mannose-type N-glycans.

Indexed as

BiocatalysisCatalytic DomainCloning, MolecularCrystallography, X-RayEnterococcus faecalisGlycoproteinsHydrogen-Ion ConcentrationMannosidasesPolysaccharidesSubstrate SpecificityGlycoproteinsMannosidasesPolysaccharidesalpha-mannosidasecrystal structureglycoprotein modificationmannosidaseN-glycan enzymatic modification

Identifiers

PMID31552675
PMCPMC7012691
OpenAlexW2976226488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.